Futura Medical Share Discussion Threads

[j777j] 11/7/2019 11:17

Fum projected $1 billion peak sales. Cialis maker Icos was sold for $2.3 billion to Eli Lilly,on annual sales around $600 million.Eli Lilly paid that amount to secure the 50% joint venture on Cialis ,it did not already own. It means there could be considerable upside if trials are successful. Arguably the value of the med gel is far higher than what was in effect a mere Viagra clone. Fum have the biggest and most disruptive innovation in the ED market for two decades.

[brucie5] 11/7/2019 09:35

Well I like your enthusiasm. And maybe you've managed to cheer the market a little bit. :)

[ih_116147] 11/7/2019 09:26

Takeover or Big Partnership ? whatever comes the share price will explode higher ...Erectile dysfunction market is $5.6 BILLION and FUM unique ED gel will capture a large part of that market .Fair Value should be closer to £2 by now and higher on Phase 3 success .

[brucie5] 08/7/2019 17:27

Well, in this market, let alone the world of ongoing clinical trials, potential is something that has to be severely risk adjusted. I would be happy with 60p.

[j777j] 08/7/2019 11:41

By november they would have had 6 weeks to analyse the phase 3 trial data,so anytime after that. If results are great Liberum have 140p price target. Not often you can buy into something that technically could yield a 300% return 3 months. Gla and if anyone makes loads,please donate something to your favourite charity as token of gratitude.

[brucie5] 08/7/2019 10:59

Doubled up. Looks over bought on the one hand, and yet... When are the next results due?

[j777j] 08/7/2019 10:13

I would imagine the share price will levitate back towards the 60p levels as phase 3 results and the pain gel UK marketing approval edge ever closer. Gla

[black bird] 08/7/2019 08:08

one billion Mkt it has been said, 1% of 1 bn =1 ,000,000 10% profit 1,000,000 simple's Meerkat. BB

[ragnarr] 05/7/2019 18:27

Thanks for the correction :-0

[j777j] 05/7/2019 17:43

Also don't forget that LO bought a shed load at the 56p placing level.So they are not making that much.

[j777j] 05/7/2019 17:12

LO were rather too long in nanoco,so I guess needed to sell some winner to pay for losers. Lo do not have 203 million shares,that is the share capital of the co,actually 204 million. Lo own 30m out of 204m.

[guessing] 05/7/2019 15:24

yes exactly, sold 1.2% of their nearly 16% holding after making several hundred percent profit or their original investment.

[wantage] 05/7/2019 15:24

LO taking profits by default. Most likely fund is overweight and has to reduce.-

[ragnarr] 05/7/2019 15:09

sorry 204 and a bit mil

[ragnarr] 05/7/2019 15:08

Lombard Odier taken a bit of profit - explains the drop - still got 203m shares

[guessing] 05/7/2019 14:44

Great time to top-up / buy in. FUM has a near term share price target of 60p and after TPR100 approval and news on MED2005 this will be £1.40+

[tiananmen] 05/7/2019 14:31

Excellent opportunity to top up at the moment, it's a win win situation now. Those selling now are looking for a quick buck whereas it's an opportunity now to improve our averages, the last 2 weeks have shown how quick this will move, the situation hasn't changed, this will rocket up close to the trial results and those holding and topping up will be the winners

[j777j] 05/7/2019 13:40

No, has very strong safety profile. Bottoms up.

[kop202] 05/7/2019 13:31

Are there any side effects?For example do you have to wear a glove when applying the gel to stop your fingers from stiffening up?

[j777j] 05/7/2019 07:46

When one realises that Eli Lilly paid $2.3 billion for the remaining 50% of Cialis maker Icos,on top of an upfront payment of $75 million after only stage 2 trials,Futura's potential becomes obvious. Futura have hugely disruptive products here. A topical ED gel that beats the pants off the competition in efficacy,speed and safety. Topical pains gels that work up to 10 x faster than currently available products. The $90 million expected in upfront and milestones alone covers the market cap. Then 15% royalties will generate huge recurring revenues. Billion dollar opportunity here

[huntie2] 04/7/2019 17:44

Why the sudden drop today?

[glavey] 04/7/2019 15:32

The point of a trial is, surely, that you don't get news until it's complete and the results fully analysed. Meantime the excitement of rubbing one's member with gel is bound to produce a few false positives in the interim, one would have thought.

[glasgow13] 04/7/2019 14:50

good or bad

[j777j] 04/7/2019 13:58

Almost 100% upside on Liberum's current fair value at 60p. The upside is 140/280p. News can come anytime.